Coverage
-
September 14, 2012
Impax Laboratories Inc. on Friday inked a deal with two Johnson & Johnson subsidiaries, giving Impax licensing rights to produce generic versions of the attention deficit hyperactivity disorder drug Concerta and putting to rest a lengthy patent infringement battle against the generic drugmaker.
1 other articles on this case.
View all »